• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Etched Nanopillars Kill Bacteria, Fungi on Titanium Implants

      Cells Release Insulin in Response to Music

      Cells Release Insulin in Response to Music

    • Radiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Portable and Radiation-Free Imaging with Magnetic Nanoparticles

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Imaging Technique Reveals Living Brain Tissue in its Complexity

      Wearable Ultrasound for Deep Tissue Monitoring

      Wearable Ultrasound for Deep Tissue Monitoring

    • Cardiology
      Ultrasound-Equipped Bra Monitors for Breast Cancer

      Ultrasound-Equipped Bra Monitors for Breast Cancer

      3D Printed Heart Muscle Beats

      3D Printed Heart Muscle Beats

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Wireless Patch Monitors, Paces Heart and then Biodegrades

      Photonic Radar Monitors Breathing from a Distance

      Photonic Radar Monitors Breathing from a Distance

    • Surgery
      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Droplet Battery Harnesses Ionic Gradients for Bioelectronic Implants

      Implantable Bioreactor for Kidney Cells

      Implantable Bioreactor for Kidney Cells

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

    • Nanomedicine
      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Nanorobots Release Reactive Oxygen Species to Kill Fungal Biofilms

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Bottlebrush Nanoparticles Deliver Immunostimulatory Drugs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Deliver mRNA Therapy to the Lungs

      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

    • Military Medicine
      Wearable Can Take Multiple Sweat Samples

      Wearable Can Take Multiple Sweat Samples

      Wound Dressing Detects Infection, Changes Color

      Wound Dressing Detects Infection, Changes Color

      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

    • Rehab
      Optical Strain Sensors for Rehab

      Optical Strain Sensors for Rehab

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Growth Factor-Loaded Microparticles Enhance 3D Bioprinted Muscle

      Brain Computer Interface Decodes Speech and Facial Expressions

      Brain Computer Interface Decodes Speech and Facial Expressions

      Semi-Automated Manufacture of E-Skin Sensors

      Semi-Automated Manufacture of E-Skin Sensors

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

The Triple Negative Breast Cancer Treatment Market To Take A Satiated Turn In The Next 10 Years

June 3rd, 2021 Persistence Market Research Releases

The Triple-Negative Breast Cancer Treatment Market is all set to reach US$ Expand 1.6X between 2020 to 2030 at a CAGR of 5%. With technological advancements engulfing the healthcare vertical, VR (virtual reality) and AR (Augmented Reality) are being incorporated to train the medical interns and also for surgery simulation and patient treatment. As of now, virtual impairments, cancer, depression, autism are being treated with VR. The others are expected to follow suit soon.

Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the risk of developing cancer before the age of 75 years is around 20.2% and that of dying from cancer before the age of 75 years is around 10.6%. According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer were diagnosed among women and approximately 2,670 cases were diagnosed in men. Thus, rising prevalence of breast cancer among the population is expected to propel the growth of the triple-negative breast cancer treatment market over the coming years.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14305 

Companies covered in Triple Negative Breast Cancer Treatment Market Report

  • AstraZeneca plc.
  • Pfizer, Inc.
  • Hoffman – La Roche Ltd.
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Mylan N.V.
  • Eli Lilly and Company
  • Celgene Corporation
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.

Request For Customization of Report @ https://www.persistencemarketresearch.com/request-customization/14305

Persistence Market Research predicts that the global triple-negative breast cancer treatment market will exhibit a CAGR of around 5% over the forecast period (2020-2030).

Key Takeaways from Triple-Negative Breast Cancer Treatment Market Study    

  • Based on drug, paclitaxel is expected to gain traction in the global triple-negative breast cancer treatment market during the forecast period, owing to its efficacy.
  • The hospital pharmacies segment is expected to be the most attractive segment in the global triple-negative breast cancer treatment market by distribution channel, and will hold the highest market share.
  • North America will dominate the global triple-negative breast cancer treatment market by region over the forecast period, owing to growing population, rising prevalence of breast cancer, and excessive consumption of tobacco and alcohol.
  • The triple-negative breast cancer treatment market is expected to experience a short-term negative impact during the COVID-19pandemic crisis, owing to labor shortage, transportation restrictions, supply chains issues, and shortage of medical instruments for cancer.

“Rising prevalence of breast cancer, increased focus on innovation of robust drug pipeline and combination therapies, developments in therapeutic areas, and growing concerns about maintaining environmental hygiene after the COVID-19 outbreak are factors expected to contribute to the growth of the global triple-negative breast cancer treatment market,” says a PMR analyst.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/14305

Accelerated Expansion and Acquisitions & Collaborations by Leading Industry Players to Meet Unmet Demand

Leading manufacturers in the global triple-negative breast cancer treatment market are extensively focusing on expansion of their manufacturing. Government initiatives such as awareness programs, investments by regional manufacturers, and increasing healthcare expenditure are some of the key trends expected to drive the triple-negative breast cancer treatment market over the coming years.

  • For instance, in April 2018, Servier acquired Shire’s oncology business to gain direct commercial access in the U.S. At present, Servier offers Oncaspar in the U.S. Prior to this, Shire and Baxalta were involved in a US$ 32billion merger in 2016.
  • Additionally, in January 2018, Sanofi announced its plan to acquire ELOCTATE.

What Does the Report Cover?        

Persistence Market Research offers a unique perspective and actionable insights on the triple-negative breast cancer treatment market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of drug (doxorubicin, cyclophosphamide, paclitaxel, docetaxel, carboplatin/cisplatin, and others) and distribution channel (hospitals, cancer research institutes, and retail clinics), across seven key regions.

Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry

Related Reports:

Aquaculture Feed And Pharmaceutical Market:

The report, titled “Aquaculture Feed and Pharmaceutical Market: Global Industry Analysis 2012–2016 and Forecast 2017–2025,” portrays that the cumulative revenue generated by the market is projected to increase 1.8X over the forecast period from 2017-2025.

Advanced Medical Nutrition Market:

The global parenterally administered medical nutrition market is anticipated to grow from over US$ 3,200 Mn in 2016 to more than US$ 6,000 Mn by 2025 end. This represents a CAGR of 7.2% in terms of value over the forecast period.

Non-Melanoma Skin Cancer Treatment Market:

The A&Z non-melanoma skin cancer treatment market is anticipated to be valued at more than US$ 705 Mn at the end of the forecast period making it larger than the rest of the APAC region combined.

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Sign up and submit a press release

Sponsored
Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Clarius L20 HD3 Receives Highest Image Quality Ranking Among Five Point-of-Care Ultrasound Devices

Viral Vector Manufacturing in Gene Therapy and Vaccine Development

Health and Clean Air: Why Indoor Ventilation Matters

Health and Clean Air: Why Indoor Ventilation Matters

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

MedTech Outlook 2023 for Latin America Released

MedTech Outlook 2023 for Latin America Released

interviews & reviews
Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

Refillable Device for Drug Delivery Past the Blood-Brain Barrier: Interview with Mike Maglin, CEO at CraniUS

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

EarliPoint Evaluation System for ASD Diagnosis: Interview with Tom Ressemann, CEO of EarliTec Dx

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

Visually Guided Uterine Biopsies in Physician’s Office: Interview with Allison London Brown, CEO of LUMINELLE

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

AI-Powered Pain Relief: Interview with Claire Smith, VP at Nevro

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

MISHA Knee Shock Absorber: Interview with Anton Clifford, CEO of Moximed

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

Shelf-Stable Breast Milk Powder: Interview with Dr. Vansh Langer, CEO at BBy

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email